1d
GlobalData on MSNAscletis announces positive results in Phase Ib oral GLP-1RA trialThe Hong Kong company saw a reduction in body weight across both cohorts with no serious adverse events reported.
57mon MSN
Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...
New GLP-1RA weight loss drugs like Like Ozempic and Wegovy have become extremely popular in recent months but researchers ...
8h
GlobalData on MSNZealand Pharma steadfastly upholds amylin-based obesity drug strategyZealand’s CEO Adam Steensberg said that the company is “exactly where it wants to be” in terms of its partnering and ...
A study conducted using electronic health record data from a collective of U.S. health care systems found that most adults ...
Does GLP-1RA use impact the risk of thyroid cancer? GLP-1RAs are highly effective medications used to treat T2D and obesity while simultaneously conferring protection against cardiovascular ...
9d
News Medical on MSNDiabetes medications may help lower COPD flare-up risk, study findsThe study reveals SGLT-2is are linked to fewer COPD exacerbations in type 2 diabetes, suggesting a need for further clinical ...
Efruxifermin (EFX) with GLP-1RA significantly reduces hepatic fat fraction and improves fibrosis in MASH and T2D patients. The study involved 31 patients over 12 weeks, showing EFX enhances GLP ...
Cochran Veterans Hospital in St. Louis. “Our approach has allowed us to build a comprehensive atlas mapping the associations of GLP-1RA spanning all organ systems,” he said. “The study’s ...
A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic ...
Greater weight loss was linked to lower discontinuation rates, with a 1% reduction in weight lowering the hazard of discontinuation by 3.1% in patients with type 2 diabetes and 3.3% in those without.
1d
Pharmaceutical Technology on MSNGLP-1RAs and opioid use disorder: a new frontier in addiction treatmentWhile medications such as methadone, buprenorphine, and naltrexone are FDA-approved for treating opioid use disorder, they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results